Keywords: antisoma, reports, narrowed, losses, future, strong, roche

Antisoma reports narrowed losses; future strong on Roche product deal

Article | 29 September 2003

Print This

The UK's Antisoma, which specializes in the development of monoclonal antibodies, has reported a sharp improvement in losses for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in